34 related articles for article (PubMed ID: 8753775)
1. Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.
Lapchak PA; Wu Q
J Neurol Neurophysiol; 2011; 2011():. PubMed ID: 22400125
[TBL] [Abstract][Full Text] [Related]
2. Brain distribution and elimination of recombinant human TIMP-1 after cerebral ischemia and reperfusion in rats.
Sa Y; Hao J; Samineni D; Clark J; Pyne-Geithman G; Broderick J; Lu A
Neurol Res; 2011 May; 33(4):433-8. PubMed ID: 21535944
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of three inhibitors of TACE in blocking the converting of pro-TNF alpha into sTNF alpha.
Wang Z; Wang Y; Zhu K; Guo L; Yang Y
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):116-20. PubMed ID: 12973924
[TBL] [Abstract][Full Text] [Related]
4. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
Lee MH; Verma V; Maskos K; Nath D; Knäuper V; Dodds P; Amour A; Murphy G
Biochem J; 2002 May; 364(Pt 1):227-34. PubMed ID: 11988096
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.
Lapchak PA
Curr Neurol Neurosci Rep; 2002 Jan; 2(1):38-43. PubMed ID: 11898581
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNF antibody treatment of Crohn's disease.
van Deventer SJ
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I114-20. PubMed ID: 10577987
[No Abstract] [Full Text] [Related]
7. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme.
Maskos K; Fernandez-Catalan C; Huber R; Bourenkov GP; Bartunik H; Ellestad GA; Reddy P; Wolfson MF; Rauch CT; Castner BJ; Davis R; Clarke HR; Petersen M; Fitzner JN; Cerretti DP; March CJ; Paxton RJ; Black RA; Bode W
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3408-12. PubMed ID: 9520379
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.
Pagenstecher A; Stalder AK; Kincaid CL; Shapiro SD; Campbell IL
Am J Pathol; 1998 Mar; 152(3):729-41. PubMed ID: 9502415
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and processing of pro-TNF-alpha.
Gearing AJ; Beckett P; Christodoulou M; Churchill M; Clements JM; Crimmin M; Davidson AH; Drummond AH; Galloway WA; Gilbert R
J Leukoc Biol; 1995 May; 57(5):774-7. PubMed ID: 7759957
[TBL] [Abstract][Full Text] [Related]
10. The importance of shedding of membrane proteins for cytokine biology.
Müllberg J; Althoff K; Jostock T; Rose-John S
Eur Cytokine Netw; 2000 Mar; 11(1):27-38. PubMed ID: 10705296
[TBL] [Abstract][Full Text] [Related]
11. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
Black RA; Durie FH; Otten-Evans C; Miller R; Slack JL; Lynch DH; Castner B; Mohler KM; Gerhart M; Johnson RS; Itoh Y; Okada Y; Nagase H
Biochem Biophys Res Commun; 1996 Aug; 225(2):400-5. PubMed ID: 8753775
[TBL] [Abstract][Full Text] [Related]
12. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
13. Partial purification and characterization of a tumor necrosis factor-alpha converting activity.
Robache-Gallea S; Bruneau JM; Robbe H; Morand V; Capdevila C; Bhatnagar N; Chouaib S; Roman-Roman S
Eur J Immunol; 1997 May; 27(5):1275-82. PubMed ID: 9174621
[TBL] [Abstract][Full Text] [Related]
14. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
Kassiri Z; Oudit GY; Sanchez O; Dawood F; Mohammed FF; Nuttall RK; Edwards DR; Liu PP; Backx PH; Khokha R
Circ Res; 2005 Aug; 97(4):380-90. PubMed ID: 16037568
[TBL] [Abstract][Full Text] [Related]
15. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
